US Man Wearing Large Metallic Chain Sucked Into MRI Machine
The 61-year-old man entered the magnetic resonance imaging room while the machine was in progress, according to a report in New York Post. He was wearing a large metallic chain around his neck, causing him to be immediately sucked into the machine, which has a massive magnet in it.
As per the authorities, the man suffered a medical episode after he was forcefully pulled into the machine. He was rushed to a local hospital, where he's listed in critical condition with unknown injuries. It remains unclear how he gained access to the medical suite during an active scan.
An investigation has been launched to probe how he gained access to the room.
How do MRI machines work?
The MRI machines are designed to detect disease or ailments using powerful magnets to create a strong magnetic field to scan the body and produce images of its "non-bony parts or soft tissues".
The magnetic strength extends beyond the machine and exerts a powerful force on objects of iron, some steels, and other magnetisable objects. The patients are carefully placed inside the machine after removing all metallic objects, jewellery and informing the technicians about any implants or medical conditions.
Teen sucked into meat grinder
Earlier this week, a teenager in the US state of California was killed after being sucked into a meat grinder at one of the fast food factories. The unnamed 19-year-old worked as a sanitation employee at Tina's Burritos food processing plant in Vernon, California. He was cleaning the meat grinder during the after-hours sanitation shift.
Vernon Police Department's Sgt. Daniel Onopa informed that the incident occurred around 9:30 pm when the machine somehow got activated and sucked him inside. He said that other workers heard him scream and tried to stop the machine. When police arrived, the victim had already died.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
18 hours ago
- News18
Ghislaine Maxwell Reveals ‘100 Different People' Linked To Epstein Under Immunity Deal: Report
Last Updated: Ghislaine Maxwell answered questions about 100 people linked to Epstein during a two-day interrogation. Serving a 20-year sentence, she seeks clemency from President Trump. Ghislaine Maxwell's attorney for the disgraced socialite claimed that she answered questions from Justice Department officials about around '100 different people" connected to the late pedophile Jeffrey Epstein, following a two-day interrogation led by Deputy Attorney General Todd Blanche, where she was granted limited immunity. According to David Oscar Markus, his client, currently serving a 20-year sentence after being convicted in Manhattan of federal sex trafficking and conspiracy charges in December 2021, was 'asked about every possible thing you could imagine – everything." 'This was the first opportunity she's ever been given to answer questions about what happened," Markus added. 'The truth will come out about what happened with Epstein, and she's the person who's answering those questions." Blanche had 'every single question" answered during the sitdown, Maxwell's attorney also said, with the British-born convict declining to plead the Fifth Amendment, the New York Post reported. 'If she lies, they could charge her with lying," Markus noted. A reporter countered, 'But didn't they charge her with lying?" referencing the two perjury counts that were later dropped by the prosecution after her conviction. 'No one is above the law — and no lead is off-limits," Blanche posted on X Tuesday in announcing he would speak with Maxwell, the NYP reported. Maxwell, 63, is currently appealing her conviction and sentence, leading some legal observers to speculate that her cooperation may be an attempt to secure clemency from President Trump. Her attorney described the commander in chief Friday as 'the ultimate dealmaker" and claimed his client had 'been treated unfairly for the past five years" and 'didn't get a fair trial." 'We hope he exercises that power in a right and just way," Markus added. Trump, after landing in Glasgow, Scotland, told reporters that 'I don't know anything about the conversation" between Blanche and Maxwell because 'I haven't really been following it." 'This is no time to be talking about pardons," the president added after saying hours earlier while leaving the White House, that 'I haven't thought" about the idea. According to ABC News, Maxwell reportedly initiated the sitdowns with the DOJ and answered questions for roughly nine hours. The limited immunity granted to Maxwell protected her from having her statements used against her in future criminal proceedings, sources told the outlet. Proffer immunity is typically granted to individuals prosecutors want cooperation from in a criminal case. The Department of Justice, in 2022, questioned Maxwell's credibility, stating in court documents that she demonstrated a 'significant pattern of dishonest conduct" and refused to accept responsibility for her crimes. As per court documents, the prior year revealed that prosecutors never seriously entertained the prospect of offering the woman dubbed 'Epstein's madam" a plea agreement after the financier was found dead in his Manhattan jail cell while awaiting his federal trial on Aug. 10, 2019. Markus noted that Epstein's attorneys had been informed that 'no potential co-conspirators would be prosecuted" as part of his talks with government lawyers following his July 2019 arrest on sex trafficking charges. 'I don't think President Trump knows that the Justice Department took the position that that promise should not be upheld," he claimed. Former Attorney General Pam Bondi hinted in a February Fox News interview that federal investigation files on Epstein, including an alleged 'client list" of powerful associates, would be disclosed – but the release never materialised. First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Indian Express
a day ago
- Indian Express
Watch: Plane nosedives and crashes onto highway in Italy, leaving 2 dead
A small plane nosedived onto an Italian highway and exploded in flames, killing two people, in Brescia this week, the New York Post reported. The Freccia RG ultralight aircraft was nose-first when it crashed into the highway road, erupting into black smoke and fire. Caught on camera, the fiery incident killed pilot Sergio Ravaglia, 75, and his partner Ann Maria De Stefano, 50, as per the New York Post. Watch the video here: Two motorists were also injured in the incident, as per officials. Soon after the incident, authorities launched a manslaughter investigation, as questions mounted over the aircraft's condition and cause of the crash. Pilot Ravaglia appeared to be attempting to complete an emergency landing on the highway but failed to regain speed, causing the aircraft to nosedive and spin out of control, as per witnesses quoted by the NY Post.
Mint
a day ago
- Mint
Male contraceptive YCT-529 a breakthrough? Birth control pill that temporarily halts sperm without hormones clears trial
In a new development, men may soon be able to equitably share the responsibility of avoiding pregnancy along with their partners as YCT-529, a birth control experimental pill has passed its initial human safety test, making another way for contraception. It will reportedly cease sperms temporarily without hinderance to hormones. Unlike conventional hormonal birth control pills, the innovative pill developed by YourChoice Therapeutics temporarily halts sperm production while leaving testosterone levels unchanged, New York Post reported. It functions by inhibiting a protein named retinoic acid receptor alpha, which is essential in the sperm creation process. Initial studies indicate that its effects are completely reversible. In tests involving male mice, YCT-529 significantly decreased sperm production, leading to reversible infertility after only four weeks of treatment. When these treated males bred with females, the drug demonstrated a 99% success rate in preventing pregnancy. Comparable outcomes were observed in male nonhuman primates, with sperm counts declining within two weeks of beginning the treatment. Importantly, fertility was fully restored in both species once the drug was discontinued. Mice recovered within six weeks, while primates regained fertility between 10 and 15 weeks. No side effects were noted in either group throughout the studies, the report added. The initial human trial of the medication included 16 healthy males aged 32 to 59, all of whom had previously had vasectomies, a surgical operation that severs and blocks the tubes transporting sperm from the testicles to prevent conception. This additional safety measure was required because no nonhormonal male contraceptive had ever been evaluated in humans before. Scientists wanted to eliminate any chance of permanently impacting fertility, in case participants wished to have children later, Nadja Mannowetz, co-founder and chief science officer of YourChoice Therapeutics, informed Scientific American. She clarified the objective was not to assess effectiveness but to determine if the drug was tolerated well and to observe how it accumulated in the body. Researchers tested multiple doses and found no concerning side effects. There were no changes in heart rate, hormone levels, inflammation, sexual function, or mood. This finding is important because hormonal contraceptives have previously been linked to side effects like mood swings, decreased libido, weight gain, and acne. Mannowetz pointed out that across all doses, the drug demonstrated good and rapid bioavailability, which means it remained active in the body without breaking down too quickly, the report mentioned.
